Why can false‑negative nucleic acid amplification test (NAAT) results lead to persistent Mycoplasma genitalium or Ureaplasma infection and chronic symptoms despite negative tests after weeks or years of antibiotic therapy?

Understanding False-Negative NAAT Results in Mycoplasma and Ureaplasma Infections

The perception of "false negatives" and chronic infections despite negative tests stems from several real phenomena: intermittent bacterial shedding causing day-to-day fluctuations in detectability, reinfection from untreated partners being mistaken for persistent infection, and the critical timing of testing relative to antibiotic therapy—not from tests missing truly present infections in most cases.

Why This Confusion Exists

1. Intermittent Bacterial Shedding Creates Testing Variability

The most compelling evidence comes from daily urine sampling studies of Mycoplasma genitalium patients. Patients with macrolide-resistant M. genitalium showed dramatic day-to-day fluctuations in bacterial load, with some testing negative at multiple time points during a 5-week observation period despite ongoing infection 1. This means a patient could genuinely test negative on Tuesday but positive on Thursday—not because the test failed, but because the organism's shedding pattern varies.

This phenomenon explains why patients and clinicians may perceive "false negatives" when the infection is actually present but undetectable on that particular day.

2. Timing of Testing After Treatment Is Critical

Multiple CDC guidelines consistently warn about testing too soon after treatment 2, 3:

• Testing within 3 weeks of completing therapy can yield false-negative results due to low organism numbers in truly persistent infections
• Conversely, NAATs can produce false-positive results within 3 weeks because they detect dead organism DNA from successful treatment

For M. genitalium specifically, wild-type (macrolide-sensitive) strains clear within 4 days of azithromycin treatment, making test-of-cure at 1 week appropriate. However, resistant strains show unpredictable fluctuations for up to 5 weeks, allowing false-negative results during this window 1.

3. Reinfection Masquerading as Persistent Infection

The majority of post-treatment positive tests represent reinfection from untreated partners, not treatment failure 2. This is the most common reason patients test negative after treatment but later test positive again:

• High reinfection rates occur when sexual partners aren't treated simultaneously
• Patients who resume sexual activity before partner treatment is complete get reinfected
• This creates the illusion of a "chronic infection that never cleared"

4. Antibiotic Resistance Drives True Treatment Failures

For M. genitalium specifically:

• Macrolide resistance exceeds 50% in many populations 4, 5
• Patients with resistant strains who receive azithromycin show persistent infection with the same genetic strain—not reinfection 6
• Doxycycline alone has only 30-40% cure rates 5
• 44% of M. genitalium infections persisted at 4 weeks after treatment in one study, strongly associated with the antibiotic regimen used 7

This means some patients genuinely have persistent infections due to inadequate treatment, not false-negative tests.

5. Sequence Variation Can Cause True False Negatives (But Rarely)

While NAATs are highly sensitive, sequence variation in primer/probe binding sites can cause genuine false-negative results 8. However, this is uncommon with commercial assays targeting conserved regions. The concern is more theoretical than practical for most clinical scenarios.

The Reality Check

For Chlamydia trachomatis specifically, doxycycline and azithromycin have 97-98% microbiological cure rates 2. These are not organisms that commonly cause "chronic infections despite treatment." When patients test positive months later, it's almost always reinfection.

For M. genitalium and Ureaplasma, the situation differs:

• M. genitalium has documented treatment failures due to resistance 7, 9, 5
• Ureaplasma has high colonization rates in asymptomatic people, making its clinical significance unclear 10
• Testing for Ureaplasma is not recommended because colonization is so common in sexually active people without disease 10

Clinical Pitfalls to Avoid

1. Don't test for cure within 3 weeks of treatment completion 2—you'll get unreliable results either way

2. Don't assume a negative test at 4 weeks means no infection if symptoms persist—consider the intermittent shedding pattern, especially for M. genitalium 1

3. Don't attribute reinfection to treatment failure—untreated partners are the usual culprit 2

4. Don't test or treat Ureaplasma routinely—colonization doesn't equal infection 10

5. For M. genitalium, obtain resistance testing before treatment when available 11, 4, 5—empiric treatment increasingly fails

What "Years of Antibiotics" Actually Represents

The scenario of patients receiving "years of antibiotics" for these infections represents poor clinical practice, not chronic infection:

• Repeated courses of antibiotics without partner treatment leads to reinfection cycles 2
• Inappropriate treatment of Ureaplasma colonization (not infection) 10
• Failure to use resistance-guided therapy for M. genitalium 4, 5
• Misattribution of symptoms to these organisms when other causes exist

The evidence does not support that properly treated, confirmed infections with appropriate antibiotics persist for years while testing negative. What exists instead is a complex interplay of reinfection, resistance, testing timing issues, and intermittent detectability that creates this clinical picture.